Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
45.1M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
22M
-
Shares change
-
+746K
-
Total reported value, excl. options
-
$1.09B
-
Value change
-
+$38.1M
-
Number of buys
-
59
-
Number of sells
-
-39
-
Price
-
$49.51
Significant Holders of Y-mAbs Therapeutics, Inc. - Common stock, par value $0.0001 per share (YMAB) as of Q4 2020
119 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - Common stock, par value $0.0001 per share as of Q4 2020.
Y-mAbs Therapeutics, Inc. - Common stock, par value $0.0001 per share (YMAB) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22M shares
of 45.1M outstanding shares and own 48.77% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (2.44M shares), BlackRock Inc. (2.42M shares), Sofinnova Investments, Inc. (2.19M shares), Cormorant Asset Management, LP (1.66M shares), VANGUARD GROUP INC (1.48M shares), Artisan Partners Limited Partnership (1.05M shares), ALLIANCEBERNSTEIN L.P. (1.01M shares), FMR LLC (1.01M shares), STATE STREET CORP (943K shares), and GOLDMAN SACHS GROUP INC (861K shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.